05.12.2012 Views

Dubai Final-v20.indd - World Allergy Organization

Dubai Final-v20.indd - World Allergy Organization

Dubai Final-v20.indd - World Allergy Organization

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

ONBREZ ® BREEZHALER ®<br />

Important note: Before prescribing, consult full prescribing information. Presentation: Inhalation powder hard capsules containing indacaterol maleate equivalent to 150 microgram<br />

(mcg) indacaterol; inhalation powder hard capsules containing indacaterol maleate equivalent to 300 mcg indacaterol. Indications: ONBREZ ® BREEZHALER ® is a long-acting beta2-agonist<br />

indicated for longterm, once-daily, maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). Dosage: Adults:<br />

recommended dosage is the once-daily inhalation of the content of one 150 mcg capsule using the ONBREZ BREEZHALER inhaler. The dosage should only be increased on medical<br />

advice. Once-daily inhalation of the content of one 300 mcg capsule using the ONBREZ BREEZHALER inhaler, has been shown to provide additional clinical benefit to some patients,<br />

e.g. with regard to breathlessness, particularly for patients with severe COPD. The maximum dose is 300 mcg once-daily. Children (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!